ARTICLE | Company News
Chiome, ADC Therapeutics deal
August 3, 2015 7:00 AM UTC
Chiome’s LivTech Inc. subsidiary granted ADC an option for exclusive, worldwide rights to develop LIV-1205 as an antibody-drug conjugate (ADC) to treat cancer. Upon exercise, LivTech will receive an ...